Drug intelligence / Profile preview

ligustrazine phosphate

Development stage
Unknown
Lead developer
Hainan Shuangcheng Pharmaceuticals
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ligustrazine phosphate (also known as tetramethylpyrazine phosphate) is a small molecule synthetic derivative of ligustrazine, an active compound originally extracted from the traditional Chinese medicinal herb *Rhizoma Chuanxiong* (Szechuan lovage). Developed and manufactured by Hainan Shuangcheng Pharmaceuticals as an injectable formulation, it primarily functions as a calcium antagonist. The drug exhibits potent vasodilatory, neuroprotective, and antiplatelet aggregation effects, which facilitate the expansion of small arteries, improvement of microcirculation, and enhancement of cerebral blood flow. It is clinically approved in China for the treatment of several conditions, including ischemic stroke, coronary heart disease, diabetic nephropathy, and knee osteoarthritis.

Brand names
注射用磷酸川芎嗪
Other names
tetramethylpyrazine phosphateLigustrazine phosphate for injection
02

Targets

VDCC (L-type voltage-dependent calcium channel (often specified further as subunits such as CaV1.2 in humans))CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)SCN11A (NaV1.9)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on ligustrazine phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ligustrazine phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call